Synergy between low‐dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal‐induced heartburn
Open Access
- 27 September 2001
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (9) , 1365-1374
- https://doi.org/10.1046/j.1365-2036.2001.01058.x
Abstract
Background: The pathophysiology of recurrent postprandial heartburn and the basis for the effectiveness of antacids or low doses of histamine H2‐receptor antagonists have not been well studied. Methods: The selected subjects (n=26) had heartburn more than four times a week for at least 2 months, which was responsive to antacids. Gastric pH and oesophageal pH were measured for 1 h before, during, and 4.5 h after ingestion of a meal over 0.5 h. Heartburn severity was assessed at 15‐min intervals beginning at the end of the meal. Each subject randomly received placebo, 75 mg ranitidine, 420 mg calcium carbonate, and ranitidine plus calcium carbonate. Values for pH were converted to acid concentration (mM) and integrated acidity was calculated from the cumulative, time‐weighted means of the acid concentrations for every second of the postprandial recording period. Results: There was a close temporal relationship between heartburn and oesophageal acidity. Most oesophageal acid exposure occurred over a 90‐min period that began approximately 45 min after the end of the meal. During this period the gastric acid concentration was less than 5% of maximal. Ranitidine significantly decreased gastric but not oesophageal acidity, whilst antacid significantly decreased oesophageal but not gastric acidity. Ranitidine plus antacid significantly decreased both gastric and oesophageal acidity. Antacid alone and ranitidine plus antacid significantly decreased heartburn severity. Conclusions: Determining integrated gastric and oesophageal acidity provides novel information regarding the pathophysiology of meal‐induced heartburn as well as the actions of low‐dose ranitidine and antacid. For subjects with meal‐induced heartburn, treatment with low‐dose ranitidine plus antacid is particularly effective in decreasing gastric and oesophageal acidity as well as heartburn severity.Keywords
This publication has 45 references indexed in Scilit:
- Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controlsDigestive Diseases and Sciences, 1996
- Pharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux DiseaseClinical Pharmacokinetics, 1996
- Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controlsDigestive Diseases and Sciences, 1996
- COMPARATIVE EFFECTS OF LIQUID ANTACIDS ON ESOPHAGEAL AND GASTRIC pH IN PATIENTS WITH HEARTBURNClinical Journal of Sport Medicine, 1995
- SELF-DIRECTED TREATMENT OF INTERMITTENT HEARTBURNClinical Journal of Sport Medicine, 1995
- Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteersDigestive Diseases and Sciences, 1992
- Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagusDigestive Diseases and Sciences, 1992
- Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal refluxDigestive Diseases and Sciences, 1991
- Acid perfusion test and 24-hour esophageal pH monitoring with symptom indexDigestive Diseases and Sciences, 1991
- In vivo andin vitro evaluation of magnesium-aluminum hydroxide antacid tablets and liquidDigestive Diseases and Sciences, 1985